Skip to content

WHWK WHWK Other Income (Expense)

Other Income (Expense) at other companies

Eli Lilly logo
Eli LillyLLY
-$65M+72.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$188.3M-39.9%
Gilead Sciences logo
Gilead SciencesGILD
$235M+172%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$10.01M-18.1%
OS Therapies logo
OS TherapiesOSTX
-$228.89K-120%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$7K-164%

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's other income (expense)?
WHWK (WHWK) reported other income (expense) of $1.33M in Q1 2026.
How has WHWK's other income (expense) changed year-over-year?
WHWK's other income (expense) decreased by 98.5% year-over-year, from $88.23M to $1.33M.
What is the long-term trend for WHWK's other income (expense)?
Over 3 years (2021 to 2025), WHWK's other income (expense) has grown at a 336.4% compound annual growth rate (CAGR), from $1.13M to $93.8M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.